RPG Life Sciences Limited (RPGLIFE.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 30.72B |
| Enterprise Value | 29.01B |
| P/E Ratio | 32.77 |
| PEG Ratio | -0.88 |
| Price/Sales Ratio | 5.33 |
| Price/Book Ratio | 6.23 |
| Enterprise/Revenue | 5.09 |
| Enterprise/EBITDA | 22.13 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.15 |
| Return On Equity | 0.21 |
Income Statement
| Revenue | 7.08B |
| Revenue/Share | 427.81 |
| Gross Profit | 2.92B |
| EBITDA | 1.47B |
| Net Income | 1.15B |
| Diluted EPS | 69.64 |
Balance Sheet
| Total Cash | 2.75B |
| Total Cash/Share | 166.56 |
| Total Debt | 200M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 3.48 |
| Book Value Per Share | 366.04 |
Price History
| 52-Week Change | -5.46 |
| 52-Week High | 2,725 |
| 52-Week Low | 1,733 |
| Moving Average 50 Days | 2,194.87 |
| Moving Average 200 Days | 2,184.2 |
Statistics
| Average Volume | 46,541 |
| Shares Outstanding | 16.54M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 24 |
| Trailing Annual Dividend Yield | 1.05 |
| Payout Ratio | 0.34 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
